Tag: PATH
-
Why GiveWell funded the rollout of the malaria vaccine
Since our founding in 2007, GiveWell has directed over $600 million to programs that aim to prevent malaria, a mosquito-borne disease that causes severe illness and death. Malaria is preventable and curable, yet it killed over 600,000 people in 2021—mostly young children in Africa.[1] Following the World Health Organization’s approval of the RTS,S/AS01 malaria vaccine…
-
IPTi for malaria: a promising intervention with likely room to scale
Summary Intermittent preventive treatment in infants (IPTi) for malaria provides preventive antimalarial medicine to children under 12 months old. It is among the most promising programs we’ve identified in our active pipeline of new interventions. Not only does IPTi appear to be highly effective at reducing clinical malaria, it’s also underutilized (more below), and the…